{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T08:26:13Z","timestamp":1726043173661},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2008,9,19]],"date-time":"2008-09-19T00:00:00Z","timestamp":1221782400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1007\/s00115-008-2522-2","type":"journal-article","created":{"date-parts":[[2008,9,19]],"date-time":"2008-09-19T04:27:35Z","timestamp":1221798455000},"page":"1135-1143","source":"Crossref","is-referenced-by-count":5,"title":["Alternativen zu Betablockern in der Migr\u00e4neprophylaxe","Alternatives to beta blockers in preventive migraine treatment"],"prefix":"10.1007","volume":"79","author":[{"given":"S.","family":"Evers","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,9,19]]},"reference":[{"key":"2522_CR1","unstructured":"Diener HC, Pfaffenrath V, Limmroth V et al. (2005) Therapie der Migr\u00e4neattacke und Migr\u00e4neprophylaxe. Gemeinsame Leitlinie der Deutschen Gesellschaft f\u00fcr Neurologie und der Deutschen Migr\u00e4ne- und Kopfschmerzgesellschaft. In: Kommission Leitlinien der Deutschen Gesellschaft f\u00fcr Neurologie (Hrsg) 3. Aufl. Thieme, Stuttgart, S\u00a0494\u2013508"},{"key":"2522_CR2","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1468-1331.2006.01411.x","volume":"13","author":"Evers","year":"2006","unstructured":"Evers S, Afra J, Frese A et al. (2006) EFNS guideline on the drug treatment of migraine \u2013 report of an EFNS task force. Eur J Neurol 13: 560\u2013572","journal-title":"Eur J Neurol"},{"key":"2522_CR3","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/0002-9149(66)90056-7","volume":"18","author":"Rabkin","year":"1966","unstructured":"Rabkin R, Stables DP, Levin NW, Suzman MM (1966) Propranolol and prophylaxis of angina pectoris. Am J Cardiol 18: 370\u2013380","journal-title":"Am J Cardiol"},{"key":"2522_CR4","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1046\/j.1468-2982.1996.1606441.x","volume":"16","author":"Diener","year":"1996","unstructured":"Diener HC, F\u00f6h M, Iaccarino C et al. (1996) Cyclandelate in the prophylaxis of migraine: a randomized, parallel, double-blind study in comparison with placebo and propranolol. Cephalalgia 16: 441\u2013447","journal-title":"Cephalalgia"},{"key":"2522_CR5","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1046\/j.1468-2982.2001.00153.x","volume":"21","author":"Diener","year":"2001","unstructured":"Diener HC, Krupp P, Schmitt T et al. (2001) Cyclandelate in the prophylaxis of migraine: a placebo-controlled study. Cephalalgia 21: 66\u201370","journal-title":"Cephalalgia"},{"key":"2522_CR6","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/s00482-007-0529-4","volume":"21","author":"Wissmann","year":"2007","unstructured":"Wissmann A, Feuersenger A, Gendolla A et al. (2007) Entwicklung eines Migr\u00e4neprophylaxe-Screeninginstruments (MPS). Schmerz 21: 430\u2013438","journal-title":"Schmerz"},{"key":"2522_CR7","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1046\/j.1468-2982.2001.00182.x","volume":"21","author":"Diener","year":"2001","unstructured":"Diener HC, Hartung E, Chrubasik J et al. for the Study Group (2001) A comparative study of acetylsalicyclic acid and metoprolol for the prophylactic treatment of migraine. A randomised, controlled, double-blind, parallel group phase III study. Cephalalgia 21: 140\u2013144","journal-title":"Cephalalgia"},{"key":"2522_CR8","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1046\/j.1468-2982.2002.t01-1-00309.x","volume":"22","author":"Diener","year":"2002","unstructured":"Diener H, Matias-Guiu J, Hartung E et al. (2002) Efficacy and tolerability in migraine prophylaxis of flunarizine in reduced doses: a comparison with propranolol 160\u00a0mg daily. Cephalalgia 22: 209\u2013221","journal-title":"Cephalalgia"},{"key":"2522_CR9","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1526-4610.1991.hed3105333.x","volume":"31","author":"Holroyd","year":"1991","unstructured":"Holroyd KA, Penzien DB, Cordingley GE (1991) Propranolol in the management of recurrent migraine: a meta-analytic review. Headache 31: 333\u2013340","journal-title":"Headache"},{"key":"2522_CR10","first-page":"271","volume":"5","author":"Diener","year":"1994","unstructured":"Diener HC, Limmroth V (1994) The treatment of migraine. Rev Contemp Pharmacother 5: 271\u2013284","journal-title":"Rev Contemp Pharmacother"},{"key":"2522_CR11","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1046\/j.1468-2982.2002.00386.x","volume":"22","author":"Silberstein","year":"2002","unstructured":"Silberstein SD, Goadsby PJ (2002) Migraine: preventive treatment. Cephalalgia 22: 491\u2013512","journal-title":"Cephalalgia"},{"key":"2522_CR12","first-page":"CD003225","volume":"2","author":"Linde","year":"2004","unstructured":"Linde K, Rossnagel K (2004) Propranolol for migraine prophylaxis. Cochrane Database Syst Rev 2: CD003225","journal-title":"Cochrane Database Syst Rev"},{"key":"2522_CR13","first-page":"268","volume":"110","author":"W\u00f6rz","year":"1992","unstructured":"W\u00f6rz R, Reinhardt-Benmalek B, F\u00f6h MG et al. (1992) Migr\u00e4neprophylaxe durch Bisoprolol. Ergebnisse einer Doppelblindstudie versus Metoprolol. Fortschr Med 110: 268\u2013272","journal-title":"Fortschr Med"},{"key":"2522_CR14","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1046\/j.1468-2982.1997.1705596.x","volume":"17","author":"Ven","year":"1997","unstructured":"Ven LL van de, Franke CL, Koehler PJ (1997) Prophylactic treatment of migraine with bisoprolol: a placebo-controlled study. Cephalalgia 17: 596\u2013599","journal-title":"Cephalalgia"},{"key":"2522_CR15","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1001\/jama.1984.03350180030025","volume":"252","author":"Stellar","year":"1984","unstructured":"Stellar S, Ahrens SP, Meibohm AR, Reines SA (1984) Migraine prevention with timolol. A double-blind crossover study. JAMA 252: 2576\u20132580","journal-title":"JAMA"},{"key":"2522_CR16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0404.1984.tb07772.x","volume":"69","author":"Tfelt-Hansen","year":"1984","unstructured":"Tfelt-Hansen P, Standnes B, Kangasneimi P et al. (1984) Timolol vs propranolol vs placebo in common migraine prophylaxis: a double-blind multicenter trial. Acta Neurol Scand 69: 1\u20138","journal-title":"Acta Neurol Scand"},{"key":"2522_CR17","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1526-4610.1980.h2004006.x","volume":"20","author":"Stensrud","year":"1980","unstructured":"Stensrud P, Sjaastad O (1980) Comparative trial of Tenormin (atenolol) and Inderal (propranolol) in migraine. Headache 20: 204\u2013207","journal-title":"Headache"},{"key":"2522_CR18","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1526-4610.1983.hed2304188.x","volume":"23","author":"Forssman","year":"1983","unstructured":"Forssman B, Lindblad CJ, Zbornikova V (1983) Atenolol for migraine prophylaxis. Headache 23: 188\u2013190","journal-title":"Headache"},{"key":"2522_CR19","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1526-4610.1987.hed2707372.x","volume":"27","author":"Johannsson","year":"1987","unstructured":"Johannsson V, Nilsson LR, Widelius T et al. (1987) Atenolol in migraine prophylaxis a double-blind cross-over multicentre study. Headache 27: 372\u2013374","journal-title":"Headache"},{"key":"2522_CR20","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1526-4610.1978.hed1801020.x","volume":"18","author":"Nanda","year":"1978","unstructured":"Nanda RN, Johnson RH, Gray J et al. (1978) A double blind trial of acebutolol for migraine prophylaxis. Headache 18: 20\u201322","journal-title":"Headache"},{"key":"2522_CR21","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1526-4610.1975.hed1502129.x","volume":"15","author":"Ekbom","year":"1975","unstructured":"Ekbom K (1975) Alprenolol for migraine prophylaxis. Headache 15: 129\u2013132","journal-title":"Headache"},{"key":"2522_CR22","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1600-0404.1977.tb01423.x","volume":"56","author":"Ekbom","year":"1977","unstructured":"Ekbom K, Zetterman M (1977) Oxprenolol in the treatment of migraine. Acta Neurol Scand 56: 181\u2013184","journal-title":"Acta Neurol Scand"},{"key":"2522_CR23","doi-asserted-by":"crossref","unstructured":"Diener HC (2000) Flunarizine for migraine prophylaxis. In: Diener HC (ed) Drug treatment of migraine and other headaches. Karger, Basel, S\u00a0269\u2013278","DOI":"10.1159\/000061597"},{"key":"2522_CR24","first-page":"306","volume":"20","author":"Evers","year":"2001","unstructured":"Evers S, Pothmann R, \u00dcberall M et al. (2001) Therapie idiopathischer Kopfschmerzen im Kindesalter. Nervenheilkunde 20: 306\u2013315","journal-title":"Nervenheilkunde"},{"key":"2522_CR25","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1001\/jama.291.8.965","volume":"291","author":"Brandes","year":"2004","unstructured":"Brandes J, Saper J, Diamond M et al. MIGR-002 Study Group (2004) Topiramate for migraine prevention: a randomized controlled trial. JAMA 291: 965\u2013973","journal-title":"JAMA"},{"key":"2522_CR26","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s00415-004-0464-6","volume":"251","author":"Diener","year":"2004","unstructured":"Diener HC, Tfelt-Hansen P, Dahl\u00f6f C et al. on behalf of the MIGR-003 Study Group (2004) Topiramate in migraine prophylaxis: results from a placebo-controlled trial with propranolol as an active control. J Neurol 251: 943\u2013950","journal-title":"J Neurol"},{"key":"2522_CR27","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1001\/archneur.61.4.490","volume":"61","author":"Silberstein","year":"2004","unstructured":"Silberstein SD, Neto W, Schmitt J, Jacobs D, MIGR-001 Study Group (2004) Topiramate in migraine prevention: results of a large controlled trial. Arch Neurol 61: 490\u2013495","journal-title":"Arch Neurol"},{"key":"2522_CR28","first-page":"CD003226","volume":"3","author":"Chronicle","year":"2004","unstructured":"Chronicle E, Mulleners W (2004) Anticonvulsant drugs for migraine prophylaxis. Cochrane Database Syst Rev 3: CD003226","journal-title":"Cochrane Database Syst Rev"},{"key":"2522_CR29","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1111\/j.1468-1331.2007.01869.x","volume":"14","author":"Lainez","year":"2007","unstructured":"Lainez MJ, Freitag FG, Pfeil J et al. (2007) Time course of adverse events most commonly associated with topiramate for migraine prevention. Eur J Neurol 14: 900\u2013906","journal-title":"Eur J Neurol"},{"key":"2522_CR30","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1001\/archneur.1995.00540270077022","volume":"52","author":"Mathew","year":"1995","unstructured":"Mathew NT, Saper JR, Silberstein SD et al. (1995) Migraine prophylaxis with divalproex. Arch Neurol 52: 281\u2013286","journal-title":"Arch Neurol"},{"key":"2522_CR31","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1046\/j.1468-2982.1997.1702103.x","volume":"17","author":"Klapper","year":"1997","unstructured":"Klapper J on behalf of the Divalproex Sodium in Migraine Prophylaxis Study Group (1997) Divalproex sodium in migraine prophylaxis: a dose-controlled study. Cephalalgia 17: 103\u2013108","journal-title":"Cephalalgia"},{"key":"2522_CR32","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1212\/WNL.58.11.1652","volume":"58","author":"Freitag","year":"2002","unstructured":"Freitag F, Collins S, Carlson H et al. Migraine Study Group (2002) A randomized trial of divalproex sodium extended-release tablets in migraine prophylaxis. Neurology 58: 1652\u20131659","journal-title":"Neurology"},{"key":"2522_CR33","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1136\/jnnp.36.4.684","volume":"36","author":"Gomersall","year":"1973","unstructured":"Gomersall JD, Stuart A (1973) Amitriptyline in migraine prophylaxis: changes in pattern of attacks during a controlled clinical trial. J Neurol Neurosurg Psychchiatry 36: 684\u2013690","journal-title":"J Neurol Neurosurg Psychchiatry"},{"key":"2522_CR34","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1212\/WNL.26.2.121","volume":"26","author":"Couch","year":"1976","unstructured":"Couch JR, Ziegler DK, Hassanein R (1976) Amitriptyline in the prophylaxis of migraine. Effectiveness and relationship of antimigraine and antidepressant drugs. Neurology 26: 121\u2013127","journal-title":"Neurology"},{"key":"2522_CR35","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1001\/archneur.1979.00500470065013","volume":"36","author":"Couch","year":"1979","unstructured":"Couch JR, Hassanein RS (1979) Amitriptyline in migraine prophylaxis. Arch Neurol 36: 695\u2013699","journal-title":"Arch Neurol"},{"key":"2522_CR36","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1001\/archneur.1987.00520170016015","volume":"44","author":"Ziegler","year":"1987","unstructured":"Ziegler DK, Hurwitz A, Hassanein RS (1987) Migraine prophylaxis. A comparison of propranolol and amitriptyline. Arch Neurol 44: 486\u2013489","journal-title":"Arch Neurol"},{"key":"2522_CR37","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1046\/j.1526-4610.2000.00089.x","volume":"40","author":"Adelman","year":"2000","unstructured":"Adelman LC, Adelman JU, Seggern R von, Mannix LK (2000) Venlafaxine extended release (XR) for the prophylaxis of migraine and tension-type headache: a retrospective study in a clinical setting. Headache 40: 572\u2013580","journal-title":"Headache"},{"key":"2522_CR38","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.clineuro.2004.03.004","volume":"107","author":"Bulut","year":"2004","unstructured":"Bulut S, Berilgen MS, Baran A et al. (2004) Venlafaxine versus amitriptyline in the prophylactic treatment of migraine: randomized, double-blind, crossover study. Clin Neurol Neurosurg 107: 44\u201348","journal-title":"Clin Neurol Neurosurg"},{"key":"2522_CR39","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1526-4610.2005.05029.x","volume":"45","author":"Ozyalcin","year":"2005","unstructured":"Ozyalcin SN, Talu GK, Kiziltan E et al. (2005) The efficacy and safety of venlafaxine in the prophylaxis of migraine. Headache 45: 144\u2013152","journal-title":"Headache"},{"key":"2522_CR40","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1046\/j.1526-4610.2001.111006119.x","volume":"41","author":"Mathew","year":"2001","unstructured":"Mathew NT, Rapoport A, Saper J et al. (2001) Efficacy of gabapentin in migraine prophylaxis. Headache 41: 119\u2013128","journal-title":"Headache"},{"key":"2522_CR41","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1001\/archneur.1985.04060060084014","volume":"42","author":"Ziegler","year":"1985","unstructured":"Ziegler DK, Ellis DJ (1985) Naproxen in prophylaxis of migraine. Arch Neurol 42: 582\u2013584","journal-title":"Arch Neurol"},{"key":"2522_CR42","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1212\/WNL.35.9.1304","volume":"35","author":"Welch","year":"1985","unstructured":"Welch KMA, Ellis DJ, Keenan PA (1985) Successful migraine prophylaxis with naproxen sodium. Neurology 35: 1304\u20131310","journal-title":"Neurology"},{"key":"2522_CR43","unstructured":"Evers S, Mylecharane EJ (2006) Nonsteroidal anti-inflammatory and miscellaneous drugs in migraine prophylaxis. In: Olesen J, Goadsby PJ, Ramadan NM et al. (eds) The headaches. 3rd edn. Lippincott, Williams & Wilkins, Philadelphia, pp\u00a0553\u2013566"},{"key":"2522_CR44","doi-asserted-by":"crossref","unstructured":"Visser WH, Malbecq W, Strohmaier K et al. (2004) Preventive treatment of migraine headache with rofecoxib. In: Olesen J, Silberstein SD, Tfelt-Hansen P (eds) Preventive pharmacotherapy of headache disorders. Oxford University Press, Oxford, pp\u00a044\u201349","DOI":"10.1093\/oso\/9780198528449.003.0007"},{"key":"2522_CR45","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1159\/000076535","volume":"51","author":"Diener","year":"2004","unstructured":"Diener H, Rahlfs V, Danesch U (2004) The first placebo-controlled trial of a special butterbur root extract for the prevention of migraine: reanalysis of efficacy criteria. Eur Neurol 51: 89\u201397","journal-title":"Eur Neurol"},{"key":"2522_CR46","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1212\/01.WNL.0000147290.68260.11","volume":"63","author":"Lipton","year":"2004","unstructured":"Lipton RB, G\u00f6bel H, Einh\u00e4upl KM et al. (2004) Petasites hybridus root (butterbur) is an effective preventive treatment for migraine. Neurology 63: 2240\u20132244","journal-title":"Neurology"},{"key":"2522_CR47","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1111\/j.1468-2982.2005.00950.x","volume":"25","author":"Diener","year":"2005","unstructured":"Diener HC, Pfaffenrath V, Schnitker J et al. (2005) Efficacy and safety of 6.25\u00a0mg t.i.d. feverfew CO2-extract (MIG-99) in migraine prevention \u2013 a randomized, double-blind, multicentre, placebo-controlled study. Cephalalgia 25: 1031\u20131041","journal-title":"Cephalalgia"},{"key":"2522_CR48","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1046\/j.1468-2982.2002.00396.x","volume":"22","author":"Pfaffenrath","year":"2002","unstructured":"Pfaffenrath V, Diener HC, Fischer M et al. on behalf of the Investigators (2002) The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis \u2013 a double-blind, multicentre, randomized placebo-controlled dose-response study. Cephalalgia 22: 523\u2013532","journal-title":"Cephalalgia"},{"key":"2522_CR49","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1046\/j.1468-2982.1996.1606436.x","volume":"16","author":"Pfaffenrath","year":"1996","unstructured":"Pfaffenrath V, Wessely P, Meyer C et al. (1996) Magnesium in the prophylaxis of migraine \u2013 a double-blind, placebo-controlled study. Cephalalgia 16: 436\u2013440","journal-title":"Cephalalgia"},{"key":"2522_CR50","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1046\/j.1468-2982.1996.1604257.x","volume":"16","author":"Peikert","year":"1996","unstructured":"Peikert A, Wilimzig C, K\u00f6hne-Volland R (1996) Prophylaxis of migraine with oral magnesium: results from a prospective, multi-center, placebo-controlled and double-blind randomized study. Cephalalgia 16: 257\u2013263","journal-title":"Cephalalgia"},{"key":"2522_CR51","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1046\/j.1468-2982.1994.1405328.x","volume":"14","author":"Schoenen","year":"1994","unstructured":"Schoenen J, Lenaerts M, Bastings E (1994) High-dose riboflavin as a prophylactic treatment of migraine: results of an open pilot study. Cephalalgia 14: 328\u2013330","journal-title":"Cephalalgia"},{"key":"2522_CR52","first-page":"244","volume":"17","author":"Schoenen","year":"1997","unstructured":"Schoenen J, Jacquy J, Lenaerts M (1997) High-dose power riboflavin as a novel prophylactic antimigraine therapy: results from a double-blind, randomized, placebo-controlled trial. Cephalalgia 17: 244","journal-title":"Cephalalgia"},{"key":"2522_CR53","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1212\/WNL.50.2.466","volume":"50","author":"Schoenen","year":"1998","unstructured":"Schoenen J, Jacquy J, Lenaerts M (1998) Effectiveness of high-dose riboflavin in migraine prophylaxis \u2013 A randomized controlled trial. Neurology 50: 466\u2013470","journal-title":"Neurology"},{"key":"2522_CR54","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1468-1331.2004.00813.x","volume":"11","author":"Boehnke","year":"2004","unstructured":"Boehnke C, Reuter U, Flach U et al. (2004) High-dose riboflavin treatment is efficacious in migraine prophylaxis: an open study in a tertiary care centre. Eur J Neurol 11: 475\u2013477","journal-title":"Eur J Neurol"},{"key":"2522_CR55","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1212\/01.WNL.0000151975.03598.ED","volume":"64","author":"Sandor","year":"2005","unstructured":"Sandor PS, Di Clemente L, Coppola G et al. (2005) Efficacy of coenzyme Q10 in migraine prophylaxis: a randomized controlled trial. Neurology 64: 713\u2013715","journal-title":"Neurology"},{"key":"2522_CR56","doi-asserted-by":"crossref","unstructured":"Mylecharane EJ (1991) 5-HT2 receptor antagonists and migraine therapy. J Neurol [Suppl 1] 238: S45\u2013S52","DOI":"10.1007\/BF01642906"},{"key":"2522_CR57","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/01.WNF.0000236766.08409.03","volume":"29","author":"Brighina","year":"2006","unstructured":"Brighina F, Palermo A, Aloisio A et al. (2006) Levetiracetam in the prophylaxis of migraine with aura: a 6-month open-label study. Clin Neuropharmacol 29: 338\u2013342","journal-title":"Clin Neuropharmacol"},{"key":"2522_CR58","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1136\/bmj.322.7277.19","volume":"322","author":"Schrader","year":"2001","unstructured":"Schrader H, Stovner LJ, Helde G et al. (2001) Prophylactic treatment of migraine with angiotensin converting enzyme inhibitor (lisinopril): randomised, placebo-controlled, crossover trial. BMJ 322: 19\u201322","journal-title":"BMJ"},{"key":"2522_CR59","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jama.289.1.65","volume":"289","author":"Tronvik","year":"2002","unstructured":"Tronvik E, Stovner LJ, Helde G et al. (2002) Prophylactic treatment of migraine with an angiotensin II receptor blocker. A randomized controlled trial. JAMA 289: 65\u201369","journal-title":"JAMA"},{"key":"2522_CR60","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1517\/13543784.15.10.1161","volume":"15","author":"Evers","year":"2006","unstructured":"Evers S (2006) Investigating prophylactic botulinum toxin type A for chronic headache disorders. Expert Opin Investig Drugs 15: 1161\u20131166","journal-title":"Expert Opin Investig Drugs"},{"key":"2522_CR61","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1046\/j.1468-2982.1997.1702109.x","volume":"17","author":"Steiner","year":"1997","unstructured":"Steiner TJ, Findley LJ, Yuen AWC (1997) Lamotrigine versus placebo in the prophylaxis of migraine with and without aura. Cephalalgia 17: 109\u2013112","journal-title":"Cephalalgia"},{"key":"2522_CR62","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1136\/jnnp.2005.063750","volume":"76","author":"Lampl","year":"2005","unstructured":"Lampl C, Katsarava Z, Diener HC, Limmroth V (2005) Lamotrigine reduces migraine aura and migraine attacks in patients with migraine with aura. J Neurol Neurosurg Psychiatry 76: 1730\u20131732","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2522_CR63","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/j.1526-4610.1990.hed3011705.x","volume":"30","author":"Sances","year":"1990","unstructured":"Sances G, Martignoni E, Fioroni L et al. (1990) Naproxen sodium in menstrual migraine prophylaxis: a double-blind placebo controlled study. Headache 30: 705\u2013709","journal-title":"Headache"},{"key":"2522_CR64","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1212\/WNL.51.1.307","volume":"51","author":"Newman","year":"1998","unstructured":"Newman LC, Lipton RB, Lay CL, Solomon S (1998) A pilot study of oral sumatriptan as intermittent prophylaxis of menstruation-related migraine. Neurology 51: 307\u2013309","journal-title":"Neurology"},{"key":"2522_CR65","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1046\/j.1526-4610.2001.111006248.x","volume":"41","author":"Newman","year":"2001","unstructured":"Newman L, Mannix LK, Landy S et al. (2001) Naratriptan as short-term prophylaxis in menstrually associated migraine: a randomised, double-blind, placebo-controlled study. Headache 41: 248\u2013256","journal-title":"Headache"},{"key":"2522_CR66","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1212\/01.WNL.0000134620.30129.D6","volume":"63","author":"Silberstein","year":"2004","unstructured":"Silberstein SD, Elkind AH, Schreiber C, Keywood C (2004) A randomized trial of frovatriptan for the intermittent prevention of menstrual migraine. Neurology 63: 261\u2013269","journal-title":"Neurology"},{"key":"2522_CR67","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1111\/j.1526-4610.2007.00855.x","volume":"47","author":"Mannix","year":"2007","unstructured":"Mannix LK, Savani N, Landy S et al. (2007) Efficacy and tolerability of naratriptan for short-term prevention of menstrually related migraine: data from two randomized, double-blind, placebo-controlled studies. Headache 47: 1037\u20131049","journal-title":"Headache"},{"key":"2522_CR68","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1212\/01.wnl.0000249114.52802.55","volume":"67","author":"MacGregor","year":"2006","unstructured":"MacGregor EA, Frith A, Ellis J et al. (2006) Prevention of menstrual attacks of migraine: a double-blind placebo-controlled crossover study. Neurology 67: 2159\u20132163","journal-title":"Neurology"},{"key":"2522_CR69","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.1468-2982.2005.01047.x","volume":"26","author":"Damen","year":"2006","unstructured":"Damen L, Bruijn J, Verhagen AP et al. (2006) Prophylactic treatment of migraine in children. Part 2. A systematic review of pharmacological trials. Cephalalgia 26: 497\u2013505","journal-title":"Cephalalgia"},{"key":"2522_CR70","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1111\/j.1526-4610.2005.00262.x","volume":"45","author":"Winner","year":"2005","unstructured":"Winner P, Pearlman EM, Linder SL et al. (2005) Topiramate for migraine prevention in children: a randomized, double-blind, placebo-controlled trial. Headache 45: 1304\u20131312","journal-title":"Headache"},{"key":"2522_CR71","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1111\/j.1526-4610.2006.00610.x","volume":"46","author":"Winner","year":"2006","unstructured":"Winner P, Gendolla A, Stayer C et al. (2006) Topiramate for migraine prevention in adolescents: a pooled analysis of efficacy and safety. Headache 46: 1503\u20131510","journal-title":"Headache"},{"key":"2522_CR72","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1600-0404.1974.tb01350.x","volume":"50","author":"Ludvigsson","year":"1974","unstructured":"Ludvigsson J (1974) Propranolol used in prophylaxis of migraine in children. Acta Neurol Scand 50: 109\u2013115","journal-title":"Acta Neurol Scand"},{"key":"2522_CR73","first-page":"1731","volume":"120","author":"L\u00fctschg","year":"1990","unstructured":"L\u00fctschg J, Vassella F (1990) Behandlung der kindlichen Migr\u00e4ne mit Flunarizin bzw. Propranolol. Schweiz Med Wochenschr 120: 1731\u20131736","journal-title":"Schweiz Med Wochenschr"},{"key":"2522_CR74","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1046\/j.1468-2982.2003.00480.x","volume":"23","author":"Sances","year":"2003","unstructured":"Sances G, Granella F, Nappi R et al. (2003) Course of migraine during pregnancy and postpartum: a prospective study. Cephalalgia 23: 197\u2013205","journal-title":"Cephalalgia"},{"key":"2522_CR75","doi-asserted-by":"crossref","first-page":"465","DOI":"10.2165\/00023210-200519060-00001","volume":"19","author":"Fox","year":"2005","unstructured":"Fox A, Diamond M, Spierings E (2005) Migraine during pregnancy: options for therapy. CNS Drugs 19: 465\u2013481","journal-title":"CNS Drugs"},{"key":"2522_CR76","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1526-4610.2006.00684.x","volume":"47","author":"Silberstein","year":"2007","unstructured":"Silberstein SD, Lipton RB, Dodick DW et al. (2007) Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial. Headache 47: 170\u2013180","journal-title":"Headache"},{"key":"2522_CR77","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/j.1468-2982.2007.01326.x","volume":"27","author":"Diener","year":"2007","unstructured":"Diener HC, Bussone G, Van Oene JC et al. TOPMAT-MIG-201(TOP-CHROME) Study Group (2007) Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study. Cephalalgia 27: 814\u2013823","journal-title":"Cephalalgia"},{"key":"2522_CR78","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1526-4610.2005.05068.x","volume":"45","author":"Dodick","year":"2005","unstructured":"Dodick DW, Mauskop A, Elkind AH et al. (2005) Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study. Headache 45: 315\u2013324","journal-title":"Headache"},{"key":"2522_CR79","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/PL00007866","volume":"249","author":"Vahedi","year":"2002","unstructured":"Vahedi K, Taupin P, Djomby R et al. DIAMIG investigators (2002) Efficacy and tolerability of acetazolamide in migraine prophylaxis: a randomised placebo-controlled trial. J Neurol 249: 206\u2013211","journal-title":"J Neurol"},{"key":"2522_CR80","unstructured":"Noone JF (1980) Clomipramine in the prevention of migraine. J Int Med Res [Suppl 3] 8: 49\u201352"},{"key":"2522_CR81","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1046\/j.1468-2982.2001.00161.x","volume":"21","author":"Goldstein","year":"2001","unstructured":"Goldstein DJ, Offen WW, Klein EG et al. (2001) Lanepitant, an NK-1 antagonist, in migraine prevention. Cephalalgia 21: 102\u2013106","journal-title":"Cephalalgia"},{"key":"2522_CR82","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/j.1526-4610.2004.446006.x","volume":"44","author":"Brandes","year":"2004","unstructured":"Brandes JL, Visser WH, Farmer MV et al. Protocol 125 study group (2004) Montelukast for migraine prophylaxis: a randomized, double-blind, placebo-controlled study. Headache 44: 581\u2013586","journal-title":"Headache"},{"key":"2522_CR83","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1212\/01.wnl.0000297551.27191.70","volume":"70","author":"Silberstein","year":"2008","unstructured":"Silberstein S, Saper J, Berenson F et al. (2008) Oxcarbazepine in migraine headache: a double-blind, randomized, placebo-controlled study. Neurology 70: 548\u2013555","journal-title":"Neurology"},{"key":"2522_CR84","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.1526-4610.1994.hed3409497.x","volume":"34","author":"Saper","year":"1994","unstructured":"Saper JR, Silberstein SD, Lake AE, Winters ME (1994) Double-blind trial of fluoxetine: chronic daily headache and migraine. Headache 34: 497\u2013502","journal-title":"Headache"},{"key":"2522_CR85","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1046\/j.1526-4610.1999.3910716.x","volume":"39","author":"d","year":"1999","unstructured":"d\u2019Amato CC, Pizza V, Marmolo T et al. (1999) Fluoxetine for migraine prophylaxis: a double-blind trial. Headache 39: 716\u2013719","journal-title":"Headache"},{"key":"2522_CR86","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1046\/j.1526-4610.1999.3901028.x","volume":"39","author":"Landy","year":"1999","unstructured":"Landy S, McGinnis J, Curlin D, Laizure C (1999) Selective serotonin reuptake inhibitors for migraine prophylaxis. Headache 39: 28\u201332","journal-title":"Headache"},{"key":"2522_CR87","doi-asserted-by":"crossref","unstructured":"Whitmarsh TE, Coleston-Shields DM, Steiner TJ (1997) Double-blind randomized placebo-controlled study of homoeopathic prophylaxis of migraine Cephalalgia 17: 600\u2013604","DOI":"10.1046\/j.1468-2982.1997.1705600.x"},{"key":"2522_CR88","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0885-3924(99)00095-0","volume":"18","author":"Ernst","year":"1999","unstructured":"Ernst E (1999) Homeopathic prophylaxis of headache and migraine. A systematic review. J Pain Symptom Manage 18: 353\u2013357","journal-title":"J Pain Symptom Manage"},{"key":"2522_CR89","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1046\/j.1468-2982.2000.00129.x","volume":"20","author":"Walach","year":"2000","unstructured":"Walach H, Lowes T, Mussbach D et al. (2000) The long-term effects of homeopathic treatment of chronic headaches: 1\u00a0year follow up. Cephalalgia 20: 835\u2013837","journal-title":"Cephalalgia"},{"key":"2522_CR90","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1054\/homp.1999.0332","volume":"89","author":"Straumsheim","year":"2000","unstructured":"Straumsheim P, Borchgrevink C, Mowinckel P et al. (2000) Homeopathic treatment of migraine: a double blind, placebo controlled trial of 68 patients. Br Homeopath J 89: 4\u20137","journal-title":"Br Homeopath J"}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-008-2522-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00115-008-2522-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-008-2522-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T21:11:32Z","timestamp":1709241092000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00115-008-2522-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9,19]]},"references-count":90,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["2522"],"URL":"https:\/\/doi.org\/10.1007\/s00115-008-2522-2","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"value":"0028-2804","type":"print"},{"value":"1433-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,9,19]]}}}